Dongsung Pharmaceutical Co., Ltd.(KR:002210)
₩1,026.00+6.00 (+0.59%)
KR:002210
Dongsung Pharmaceutical Co., Ltd. Revenue
₩1,026.00
At close:+6.00 (+0.59%)
Want to see KR:002210 full AI Analyst Report?
Dongsung Pharmaceutical Co., Ltd. (002210) Revenue
Dongsung Pharmaceutical Co., Ltd. Revenue
Dongsung Pharmaceutical Co., Ltd. had a revenue of 22.08B in the quarter ending Jun 30, 2026, with 15.48%. This bring the company's revenue in the last twelve months to 82.07B, Increased 2.66%. In the fiscal year ending Mar 31, 2026, Dongsung Pharmaceutical Co., Ltd. had annual revenue of 87.17B with -1.45% growth.
- Revenue (ttm)
- 82.07B
- Revenue Growth
- -11.67%
- P/S Ratio
- 1.11
- Revenue/Employee
- KRW 283,937,769
- Employees
- 307
- Market Cap
- KRW 96.86B
Revenue Chart
Dongsung Pharmaceutical Co., Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 87.17B | -1.28B | -1.45% |
| Dec 31, 2024 | 88.45B | -145.35M | -0.16% |
| Dec 31, 2023 | 88.59B | -4.73B | -5.07% |
| Dec 31, 2022 | 93.33B | 8.92B | 10.57% |
| Dec 31, 2021 | 84.41B | -3.39B | -3.86% |
| Dec 31, 2020 | 87.80B | 1.26B | 1.46% |
| Dec 31, 2019 | 86.54B | -5.38B | -5.85% |
| Dec 31, 2018 | 91.91B | 9.53B | 11.56% |
| Dec 31, 2017 | 82.39B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

